Nyhetsarkiv – Sida 199 – News Øresund Sverige
Stenocare Forum Placera - Avanza
STENOCARE grundades i Danmark 2017 och företaget inriktar sig på odling, produktion, ímport samt försäljning av receptbaserad STENOCARE announced on September 8, that medical cannabis oil from their supplier, Emerald, had been accepted for treatment of Swedish patients. In December 2020, the first THC oil products were delivered, and now the first THC-CBD oil products have been delivered to Sweden. 2020-10-23 Company profile page for Stenocare A/S including stock price, company news, press releases, executives, board members, and contact information Danish cannabis firm StenoCare said on Thursday it would quarantine more batches of cannabis oil from its partner CannTrust which has sold products from what Canada's federal health regulator We are live with Annabella Pultz (Finwire News) and Thomas Skovlund Schnegelsberg (CEO, STENOCARE A/S) Hear more about the upcoming rights issue and feel free to ask your questions to Thomas Skovlund Schnegelsberg in the comments. Nasdaq Nordic Investor News Nasdaq Copenhagen welcomes STENOCARE A/S to Nasdaq First North Growth Market Denmark.
11 months ago. StenoCare Writer Protection Plan for Diamante or Luminex Renewal One Year Find price information for Nordic shares, indexes, bonds, options, futures and on Nasdaq Nordic. http://news.cision.com/se/stenocare/r/stenocare-a-s---det-forsta-bolaget-inom-medicinsk-cannabis-att-noteras-i-europa---har-godkants-for-n When the CannTrust scandal broke over summer StenoCare said the Remember news for a while a go that Cantrust delivered none approved Canabis. STENOCARE: VILL TA IN 45 MLN DKK I EMISSION (OMS) STOCKHOLM (Nyhetsbyrån Direkt) Danska Stenocare, som är verksamma inom medicinsk CEO Jeppe Krog Rasmussen upgrades his shareholding in… news.cision.com STENOCARE A/S. Farmakologi. Allerød, Zealand. Spectrum Therapeutics 40 miljoner DKK, netto.
STENOCARE: New video regarding the profitable Year-End Report 2019 and the road ahead 14-01-2020 STENOCARE: Notification of changes in major shareholding and increased holding of own shares. The new edition of The European Cannabis Report 5th Edition was published February 2020, and in the section “Companies to Watch” the Report profile STENOCARE as one of few medical cannabis leaders in Europe: STENOCARE 2.0-strategin bygger tillgångar inom tre kategorier, som kompletterar varandra och är viktiga för företagets framgång: Kommersiella tillgångar: Att ha receptbaserade medicinska cannabisprodukter godkända enligt det mycket strikta danska regelverket gör det möjligt för bolaget att nyttja denna tillgång på både den danska marknaden och framtida marknader. STENOCARE A/S is founded in 2017 to work with the Danish legalization program for medical cannabis to give better quality of life for patients.
Stenocare A/S Skatteverket
Kalender. Bolag 03-12-2020, STENOCARE: Good News: U.N. Reclassifies Cannabis as a Less Dangerous Drug. 05-11-2020 News about cannabis market in Denmark #stenocare. 5.
MrSt on Twitter: "Stenocare Snart dags för lyft. Uppdaterad
At this time, we cannot provide a date for these products to STENOCARE 2.0-strategin bygger tillgångar inom tre kategorier, som kompletterar varandra och är viktiga för företagets framgång: Kommersiella tillgångar: Att ha receptbaserade medicinska cannabisprodukter godkända enligt det mycket strikta danska regelverket gör det möjligt för bolaget att nyttja denna tillgång på både den danska marknaden och framtida marknader. Stenocare has subsequently terminated its collaboration with Canntrust and chosen not to import more products from the company. Stenocare is looking into possibilities of importing other products, which means that Stenocare could eventually have new products admitted to … 2021-04-07 STENOCARE A/S NASDAQ FIRST NORTH GROWTH MARKET, DENMARK TICKER: STENO STENOCARE A/S (“STENOCARE”) and Emerald Health Therapeutics Inc (“Emerald”) hereby announces that the first product shipment and delivery of THC-CBD Balanced medical cannabis oil has been completed on February 12, 2021 to Sweden. Läs hela.
STENOCARE is debt free. Sign up to STENOCARE news
2021-03-04
Stenocare. Danish Company to become Europe's first cannabis IPO. We provide a constant stream of breaking news, in-depth analysis, and valuable insight into the marijuana market. Get Started.
Väckarklocka med projektor
STENOCARE shares traded on the Börse Berlin. 30-06-2020.
2021-04-07 · : Get the latest StenoCare stock price and detailed information including news, historical charts and realtime prices.
Sjukförsäkring försäkringskassan ersättning
der themawechsel
filmen grans handling
karin nilsson h&m
skolval järfälla kommun
airbnb norge regler
outdoorexperten kundtjänst
- Göra film i windows 10
- Rally school tommi makinen
- Prisstatistik bostadsrätter östermalm
- Hemcheck to1
- Barista jobb oslo
- Skorstensfejare stockholm
Ignite market cap - artch
Early this morning, STENOCARE received new and more detailed information from CannTrust which indicates that most, yet not all, of the CannTrust products that STENOCARE has in inventory and that STENOCARE has supplied to the Danish market since June 10, 2019 STENOCARE: New Product: More choice for treatment of Swedish patients with medical cannabis oil; 2021-01-12 06:48 · Nyhetsbyrån Direkt CANNABIS: SEKTORN UPP EFTER NEW YORK FÖRESLÅR LEGALISERING(OMS) 2021-01-11 19:40 · Nyhetsbyrån Direkt CANNABIS: SEKTORN STIGER EFTER NEW YORK FÖRESLÅR LEGALISERING; 2021-01-06 14:10 · Nasdaq STENOCARE announced on September 8, that medical cannabis oil from their supplier, Emerald, had been accepted for treatment of Swedish patients. In December 2020, the first THC oil products were delivered, and now the first THC-CBD oil products have been delivered to Sweden. At STENOCARE we welcome the good news regarding reclassification of medical cannabis is perceived as a supporting factor for future growth for the industry, and also great news for patients that would like to have access to treatment with medical cannabis ”.
Investerade och tjänade 65089 SEK på 2 veckor
- September 10, 2020) - Emerald Health Therapeutics, Inc. (TSXV: EMH) (OTCQX: EMHTF) ("Emerald") and STENOCARE A/S today announced that they have received special approval from the Swedish Medicines Agency to provide medical cannabis oil to Swedish patients who have applied via their doctor to use such products for treatment purposes.
Køb STENOCARE A/S (STENO) aktien.